Strontium based compositions and formulations for pain, pruritus, and inflammation

Abstract

The disclosure herein relates to therapeutically active compositions and formulations for treating pain, pruritus, irritation, inflammation, and tissue damage due to the irritation and inflammation. Specifically, the disclosure relates to strontium either in salt or complex form and at least one molecule selected from chlorogenic acid, agmatine, kynurenic acid, nobiletin, or tangeretin, which can be topically applied. Optionally, the formulations include enhancement agents such as vitamins, soothing agents, moisturizers, polymers and the like.

Dependencies are inferred from the claim text.